Why the study?
Does pentoxifylline improve left ventricular function and reduce Fas/APO-1 plasma concentrations in patients with idiopathic dilated cardiomyopathy?
Does pentoxifylline improve left ventricular function and reduce Fas/APO-1 plasma concentrations in patients with idiopathic dilated cardiomyopathy?
In patients with idiopathic dilated cardiomyopathy treated with pentoxifylline, a reduction in Fas/APO-1 plasma concentrations correlates with improved left ventricular function.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Daniel Skudicky (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: